SH PHARMA (02607)
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and in...
- Open
- 11.630
- High
- 11.630
- Low
- 11.430
- Prev. Close
- 11.510
- Volume
- 995.00K
- Turnover
- 11.46M
- Avg Price
- 11.516
- Bid/Ask Ratio
- -85.64%
- Amplitude
- 1.74%
- 52wk High
- 12.300
- Volume Ratio
- 0.45
- Turnover Ratio
- 0.11%
SH PHARMA Analyst Rating
View moreForecast & Rating
Sep 2, 2026Price forecast
HK$13.8720.22%
Forecast & RatingBuy
10analysts
- Strong buy50.00%
- Buy20.00%
- Hold20.00%
- Sell10.00%
- Strong sell0.00%
News
- Tip Ranks · Sep 3 at 09:38 AM
Shanghai Pharmaceuticals Updates Interim Dividend and Tax Details for H Shareholders
- PUBT · Aug 24 at 12:56 AM
Shanghai Pharma, SIIC-controlled unit, steps up innovation push via national immunotherapy lab partnership
- PUBT · Aug 13 at 01:37 AM
Shanghai Industrial Investment president Zhang Qian visits Shanghai Pharmaceuticals Central Research Institute in Beijing for R&D review
- Tip Ranks · Jul 24 at 12:08 PM
Shanghai Pharmaceuticals Finalizes Participation in Shanghai Biomedical Phase II Fund
- Global Report · Jul 22 at 09:17 AM
The 2026 Hong Kong Reality Check: Who's Actually Delivering?
- Tip Ranks · Jul 17 at 12:39 PM
Shanghai Pharmaceuticals Joins RMB Biomedical Fund in Connected Transaction
